CSF2 and neoplasm: GVAX was based on inactivated-by-radiation tumor cells, avoiding their proliferation which might lead to new tumors in the patient; moreover, they are engineered to express and secrete granulocyte-macrophage colony-stimulating factor (GM-CSF).